In This Article:
The German market has faced recent declines, with the DAX dropping 3.20% amid renewed fears about global economic growth. As investors navigate these turbulent times, identifying growth companies with high insider ownership can offer a measure of confidence and stability. In this article, we will explore three German growth companies where insiders hold up to 26% ownership, highlighting their potential resilience and alignment of interests between management and shareholders in the current economic climate.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
pferdewetten.de (XTRA:EMH) | 26.8% | 70.6% |
Stemmer Imaging (XTRA:S9I) | 25.2% | 23.2% |
Deutsche Beteiligungs (XTRA:DBAN) | 39.5% | 54.1% |
Exasol (XTRA:EXL) | 25.3% | 117.1% |
adidas (XTRA:ADS) | 16.6% | 41.8% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Beyond Frames Entertainment (DB:8WP) | 10.8% | 112.2% |
Redcare Pharmacy (XTRA:RDC) | 17.7% | 52.1% |
Friedrich Vorwerk Group (XTRA:VH2) | 18% | 24.6% |
elumeo (XTRA:ELB) | 25.8% | 120.2% |
Let's take a closer look at a couple of our picks from the screened companies.
Brockhaus Technologies
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Brockhaus Technologies AG is a private equity firm with a market cap of €294.62 million.
Operations: The firm's revenue is primarily derived from its Security Technologies segment (€37.03 million) and Financial Technologies segment (€174.59 million).
Insider Ownership: 26.6%
Brockhaus Technologies is forecasted to grow revenue by 16.8% annually, outpacing the German market's 5.4%. Despite a net loss of €6.65 million in H1 2024, up from €0.765 million last year, the company expects significant revenue growth, targeting €220-240 million for 2024 and €290-320 million for 2025. Trading at a substantial discount to its estimated fair value and with earnings projected to grow by 93% per year, Brockhaus aims for profitability within three years despite low anticipated return on equity (5.3%).
-
Take a closer look at Brockhaus Technologies' potential here in our earnings growth report.
-
Our valuation report here indicates Brockhaus Technologies may be undervalued.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.49 billion.
Operations: The company's revenue segments include €1.74 billion from the DACH region and €391 million from international markets.